1. Therapy for Helicobacter pylori Infection Can be Improved

   • David Y. Graham
   • Hong Lu
   • Yoshio Yamaoka

   Current Opinion 17 September 2012 Pages: 725 - 736

   

2. Bevacizumab in Non-Small Cell Lung Cancer

   • Francesco Di Costanzo
   • Francesca Mazzoni
   • Federica Di Costanzo

   Leading Article 17 September 2012 Pages: 737 - 746

   

3. Novel Therapies for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

   • Richard W. Lee
   • David P. D’Cruz

   Review Article 17 September 2012 Pages: 747 - 770

4. Pharmaceutical Management of Ovarian Cancer

   • Maurie Markman

   Review Article 17 September 2012 Pages: 771 - 789

   

5. Early and Sustained Virological Response in Non-Responders with Chronic Hepatitis C

   • Gaetano Scotto
   • Vincenzina Fazio
   • Gioacchino Angarano

   Original Research Article 17 September 2012 Pages: 791 - 801

   

6. Meropenem

   • Claudine M. Baldwin
   • Katherine A. Lyseng-Williamson
   • Susan J. Keam

   Adis Drug Evaluation 17 September 2012 Pages: 803 - 838

   

7. Sucrose-Formulated Octocog Alfa

   • James E. Frampton
   • Antona J. Wagstaff

   Adis Drug Evaluation 17 September 2012 Pages: 839 - 853

   

8. Retapamulin

   • Lily P. H. Yang
   • Susan J. Keam

   Adis Drug Evaluation 17 September 2012 Pages: 855 - 873

   

9. Ciclesonide Nasal Spray

   • Sohita Dhillon
   • Antona J. Wagstaff

   Adis Drug Profile 17 September 2012 Pages: 875 - 883